Science
Mechanism of Action
This ingredient impacts skin health through diverse cellular actions. It actively promotes skin barrier function by upregulating the mRNA expression of key genes like filaggrin (FLG), involucrin (IVL), and ceramide synthase 2 (CERS2) in keratinocytes, leading to enhanced ceramide synthesis. Piperlonguminine also exhibits anti-aging properties by modulating keratinocyte-specific aging markers and influencing telomerase activity. For hyperpigmentation, it inhibits alpha-melanocyte-stimulating hormone (alpha-MSH)-induced tyrosinase synthesis, consequently reducing melanin production. Furthermore, it possesses senolytic activity, targeting senescent cells, and demonstrates anti-proliferative and anti-inflammatory effects in keratinocytes. However, it is important to note that piperlonguminine can increase reactive oxygen species (ROS) levels and potentially elevate the secretion of inflammatory mediators (e.g., GRO-αβγ, CCL5, MCP1), which warrants careful application, particularly during active inflammatory conditions.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Given its emerging status and specific formulation requirements, piperlonguminine is not currently associated with 'dusting' issues where an ingredient is included in an insufficient amount to be effective.
The Formula
Formulation
Stability
Maximum stability is observed around pH 4, with significant degradation occurring at pH 3 and pH values of 7 or higher. Approximately 10% degradation at 25°C at pH 4 is estimated to take 17 weeks. The ingredient is also highly susceptible to photo-degradation, particularly when exposed to UV light in aqueous environments. Due to its poor aqueous solubility (approximately 26 µg/ml), advanced formulation strategies such as co-solvents, surfactants, cyclodextrins, liposomes, or nanoemulsions are often necessary to enhance its solubility and skin bioavailability.
Conflicts
- pH values ≥ 7
- pH values ≤ 3
- UV light exposure
- Inflammatory conditions (due to potential to increase inflammatory mediators)
Safety
Safety Profile
Piperlonguminine has not undergone specific safety reviews by major cosmetic regulatory bodies such as CIR, SCCS, or FDA. General laboratory safety warnings advise against ingestion, inhalation, or direct contact with skin, eyes, or clothing. Further research is essential to comprehensively understand its potential toxicity in human skin cells and to establish optimal topical concentrations that maximize efficacy while mitigating the potential for inducing inflammation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting compelling in vitro benefits for skin barrier support, anti-aging, and depigmentation, the lack of comprehensive human clinical and safety data, coupled with complex formulation challenges, necessitates further research before widespread topical application.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources